Exercise in Patients Undergoing Urologic Surgery
Prospective Randomized Study of Exercise in Patients Undergoing Urologic Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Kenneth Ogan, MD
- Phone Number: (404) 778-4898
- Email: kogan@emory.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients scheduled for operative procedure with an inpatient postoperative stay are eligible for this study
- Patients willing and able to give blood sample as part of standard of care labs
- Patients willing and able to fill out questionnaire
- Patients who will fill out the step log daily
- Patients willing and able to sign informed consent
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise Group
Participants randomized to the activity intervention will aim for taking 10,000 steps per day and completing strength training exercises three times per week.
|
For the first two days after their pre-operative visit, participants will be asked to continue their present level of exercise and activity, which will be monitored by pedometer.
Participants will begin the activity intervention on study Day 3. Participants will be instructed to take 10,000 steps per day, recording their daily steps with a pedometer.
Participants also will be provided with resistance bands and instructed on how to safely perform 10 whole-body strength training exercises.
They will be instructed to perform the exercises once per day, three days a week.
Participants will complete the exercise intervention until they have surgery, which is typically 12 to 48 days after the pre-operative visit.
|
|
Active Comparator: Nutrition Group
Participants randomized to the nutrition intervention will consume a liquid over-the-counter nutrition supplement two times per day.
|
Participants in the nutrition group will be provided with a liquid over-the-counter nutrition supplement (i.e.
Boost or Ensure) to consume.
Participants will be instructed to consume 1 bottle, 2 times per day, beginning 5 days before surgery and continuing 5 days post-operatively.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Mass Index (BMI)
Time Frame: Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
Body Mass Index is a weight-to-height ratio, calculated by dividing one's weight in kilograms by the square of one's height in meters (kg/m^2) and used as an indicator of underweight, normal, overweight and obese weights.
|
Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
|
Change in Standing Task Time
Time Frame: Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
Participants will be timed, in seconds, to see how quickly they can stand up and sit down in a chair 5 times.
|
Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
|
Change in 6 Minute Walk Test (6MWT) Distance
Time Frame: Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
The 6 minute walk test (6MWT) assesses distance, in meters, walked over 6 minutes as a sub-maximal test of aerobic capacity and endurance.
|
Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
|
Change in grip strength
Time Frame: Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
Hand grip is measured in pounds using a dynamometer to test the maximum isometric strength of the hand and forearm muscles.
Grip strength is a measurement of muscle strength and tends to decline with frail states.
|
Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
|
Change in Timed Up and Go (TUG) Task
Time Frame: Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
Participants will be timed, in seconds, to see how quickly they can rise from a chair, walk 3 meters, turn around, walk back, and sit down.
|
Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
|
Change in Short-Length Food Frequency Questionnaire
Time Frame: Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
Nutritional risk will be assessed with the Short-Length Food Frequency Questionnaire.
This 18-item instrument asks participants how frequently they consume certain foods, such as alcohol, produce, grains, and fried foods.
There is not a summary score for this questionnaire, rather, the researchers can examine changes over time in foods consumed in a variety of ways.
|
Baseline, Day of surgery (up to 50 days after Baseline), Follow-up (30 days after surgery)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perioperative Complications
Time Frame: 30 days after surgery
|
The number of perioperative complications will be compared between study arms.
|
30 days after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Kenneth Ogan, MD, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB00044694
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.